Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel immunosuppressants.

Nancy R Krieger1, Sukru Emre

  • 1Recanati/Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.

Pediatric Transplantation
|December 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Donor Exclusions for Living Donor Liver Transplantation in a Tertiary Center.

Transplantation proceedings·2026
Same author

Evaluation of the Effectiveness, Safety, and Patient Satisfaction of Artificial Intelligence-Based Patient Education and Counseling for Both Recipients and Donors in the Preoperative and Postoperative Phases of Organ Transplantation.

Transplantation proceedings·2025
Same author

Multiple Swaps Tested: Rehearsal for Triple and Five Liver Paired Exchanges.

Transplantation proceedings·2024
Same author

A new method for predicting alcohol relapse in patients undergoing liver transplantation for alcohol-related liver failure: Barratt scale.

Hepatology forum·2023
Same author

The first 4-way liver paired exchange from an interdisciplinary collaboration between health care professionals and design economists.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2023
Same author

Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference.

Clinical transplantation·2023
Same journal

Single-Center Experience in Pediatric Lung Transplantation: Clinical Characteristics, Survival, and Post-Transplant Morbidity.

Pediatric transplantation·2026
Same journal

The Missing Link Between HLA Mismatch and Graft Failure: The Role of Donor-Specific Antibodies.

Pediatric transplantation·2026
Same journal

Truth or Consequences Revisited: Policymaking in Modern Organ Transplant.

Pediatric transplantation·2026
Same journal

First Single-Center Experience of Minimally Invasive Pediatric Living Donor Liver Transplantation in China.

Pediatric transplantation·2026
Same journal

Liver Retransplantation in Pediatric Recipients: A 20-Year Single-Center Experience With 25 Cases.

Pediatric transplantation·2026
Same journal

The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients.

Pediatric transplantation·2026
See all related articles

New immunosuppressive drugs show promise for organ transplant patients, offering greater specificity and fewer side effects than current treatments. Research is exploring novel biologic agents to improve long-term transplant success and manage chronic rejection.

Area of Science:

  • Immunology and Transplantation Medicine
  • Pharmacology and Drug Development

Background:

  • Current maintenance immunosuppression in organ transplantation has improved short- and long-term outcomes and reduced acute rejection.
  • Existing immunosuppressive drugs have limitations, including long-term use, lack of specificity, adverse effects (metabolic, toxicities, infection, cancer), and failure to prevent chronic rejection.

Purpose of the Study:

  • To review emerging immunosuppressive agents under investigation in experimental and clinical transplantation.
  • To highlight novel biologic agents with improved specificity and selectivity for better transplant management.

Main Methods:

  • Review of current experimental and clinical research on novel immunosuppressive agents.
  • Focus on biologic agents targeting T-cell depletion, costimulation blockade, adhesion markers, and other novel pathways.

Related Experiment Videos

Main Results:

  • Several novel immunosuppressive agents are being explored, offering potential for more targeted therapy.
  • Biologic agents demonstrate promise for enhanced specificity and selectivity compared to conventional drugs.

Conclusions:

  • Novel immunosuppressive strategies, particularly biologic agents, are crucial for overcoming the limitations of current therapies.
  • Further research and application, including in the pediatric population, are needed to optimize long-term organ transplant outcomes and address chronic rejection.